Skip to main content

Table 2 eGFR (CKD-EPI) and UACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(CKD-EPI) Albuminuria category, mg/g
< 30 30-300 > 300 Rowc
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
G1 ≥ 90 733b 29.1 (27.0-31.2) 269 9.2 (7.8-10.5) 56 1.4 (0.9-1.9) 1058 39.7 (37.4-42.0)
G2 60-89 753b 27.4 (25.1-29.6) 282 8.4 (7.0-9.7) 92 2.6 (1.9-3.2) 1127 38.3 (35.7-40.9)
G3a 45-59 242 8.0 (6.9-9.2) 132 3.6 (2.8-4.3) 49 1.4 (0.8-1.9) 423 12.9 (11.5-14.3)
G3b 30-44 84 2.7 (2.1-3.3) 75 2.1 (1.5-2.6) 36 1.0 (0.5-1.5) 195 5.8 (4.8-6.8)
G4 15-29 20 0.6 (0.2-0.9) 33 1.2 (0.6-1.7) 36 1.0 (0.5-1.6) 89 2.8 (2.0-3.6)
G5 < 15 d 0.0 (0.0-0.1) d 0.0 (0.0-0.0) 20 0.4 (0.1-0.6) 23 0.4 (0.2-0.7)
Column N, % (95% CI) c 1834 67.8 (65.7-70.0) 792 24.4 (22.3-26.4) 289 7.8 (6.5-9.1) 2915 100 (N/A)
  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. cSum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.